Start Wirkstoffe Sericin Consumption of sericin reduces serum lipids, ameliorates glucose tolerance and elevates serum adiponectin in rats fed a high-fat diet.
22.05.2012
Consumption of sericin reduces serum lipids, ameliorates glucose tolerance and elevates serum adiponectin in rats fed a high-fat diet. PDF Drucken E-Mail
Wirkstoffe - Sericin
Geschrieben von: www.ncbi.nlm.nih.gov   
Freitag, den 13. Januar 2012 um 10:41 Uhr

Abstract

The effect was examined of dietary sericin on the lipid and carbohydrate metabolism in rats fed with a high-fat diet. The rats were fed with a 20% beef tallow diet with or without sericin at the level of 4% for 5 weeks. The final body weight and white adipose tissue weight were unaffected by dietary manipulation. The consumption of sericin significantly reduced the serum levels of triglyceride, cholesterol, phospholipids and free fatty acids. Serum very-low-density lipoprotein (VLDL)-triglyceride, VLDL-cholesterol, low-density lipoprotein (LDL)-cholesterol and LDL-phospholipids were also significantly reduced by the sericin intake. Liver triglyceride and the activities of glucose 6-phosphate dehydrogenase and malic enzyme, the lipogenic enzymes, were also reduced by the sericin intake. Dietary sericin caused a marked elevation in serum adiponectin. The consumption of sericin suppressed the increases in plasma glucose and insulin levels after an intraperitoneal glucose injection. These results imply the usefulness of sericin for improving the lipid and carbohydrate metabolism in rats fed on a high-fat diet.

http://www.ncbi.nlm.nih.gov/pubmed/20699593

 
SHOPS
Nahrungsergänzungen

pilz1
Shop Nahrungsergänzungsmittel

 
Suche

Erweiterte Suche
Warenkorb
0 Produkte - 0.00 EUR
Zum Warenkorb
Shop Login